172 related articles for article (PubMed ID: 17016522)
1. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study.
Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Egberts AC; Scheffer H
Pharmacogenomics J; 2007 Oct; 7(5):318-24. PubMed ID: 17016522
[TBL] [Abstract][Full Text] [Related]
2. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
[TBL] [Abstract][Full Text] [Related]
3. HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study.
Mulder H; Cohen D; Scheffer H; Gispen-de Wied C; Arends J; Wilmink FW; Franke B; Egberts AC
J Clin Psychopharmacol; 2009 Feb; 29(1):16-20. PubMed ID: 19142101
[TBL] [Abstract][Full Text] [Related]
4. Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.
Risselada AJ; Vehof J; Bruggeman R; Wilffert B; Cohen D; Al Hadithy AF; Arends J; Mulder H
Pharmacogenomics J; 2012 Feb; 12(1):62-7. PubMed ID: 20680028
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
[TBL] [Abstract][Full Text] [Related]
6. Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.
Gregoor JG; Mulder H; Cohen D; van Megen HJ; Egberts TC; Heerdink ER; van der Weide J
J Clin Psychopharmacol; 2010 Dec; 30(6):702-5. PubMed ID: 21105285
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population.
Clark DA; Arranz MJ; Mata I; Lopéz-Ilundain J; Pérez-Nievas F; Kerwin RW
Biol Psychiatry; 2005 Sep; 58(6):435-9. PubMed ID: 16043131
[TBL] [Abstract][Full Text] [Related]
8. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
De Luca V; Müller DJ; Hwang R; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
Hum Psychopharmacol; 2007 Oct; 22(7):463-7. PubMed ID: 17702092
[TBL] [Abstract][Full Text] [Related]
9. [Association of HTR2C-759C/T and -697G/C polymorphisms with antipsychotic agent-induced weight gain].
Shao P; Zhao JP; Chen JD; Wu RR; He YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):312-5. PubMed ID: 18460774
[TBL] [Abstract][Full Text] [Related]
10. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
Opgen-Rhein C; Brandl EJ; Müller DJ; Neuhaus AH; Tiwari AK; Sander T; Dettling M
Pharmacogenomics; 2010 Jun; 11(6):773-80. PubMed ID: 20504252
[TBL] [Abstract][Full Text] [Related]
11. Further exploration of the possible influence of polymorphisms in HTR2C and 5HTT on body weight.
Bah J; Westberg L; Baghaei F; Henningsson S; Rosmond R; Melke J; Holm G; Eriksson E
Metabolism; 2010 Aug; 59(8):1156-63. PubMed ID: 20092861
[TBL] [Abstract][Full Text] [Related]
12. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.
Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977
[TBL] [Abstract][Full Text] [Related]
13. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
[TBL] [Abstract][Full Text] [Related]
14. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
[TBL] [Abstract][Full Text] [Related]
15. Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain.
Buckland PR; Hoogendoorn B; Guy CA; Smith SK; Coleman SL; O'Donovan MC
Am J Psychiatry; 2005 Mar; 162(3):613-5. PubMed ID: 15741483
[TBL] [Abstract][Full Text] [Related]
16. [Antipsychotic-induced weight gain--pharmacogenetic studies].
Olajossy-Hilkesberger L; Godlewska B; Marmurowska-Michałowskal H; Olajossy M; Landowski J
Psychiatr Pol; 2006; 40(5):1009-20. PubMed ID: 17217242
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK
Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
[TBL] [Abstract][Full Text] [Related]
18. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
Molero P; Ortuño F; Zalacain M; Patiño-García A
Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
[TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
Al Hadithy AF; Ivanova SA; Pechlivanoglou P; Semke A; Fedorenko O; Kornetova E; Ryadovaya L; Brouwers JR; Wilffert B; Bruggeman R; Loonen AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):475-81. PubMed ID: 19439249
[TBL] [Abstract][Full Text] [Related]
20. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
